Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

GeneReach Biotechnology Corp. (4171) Stock Price & Analysis

4171 Stock Chart & Stats

NT$15.00-NT$0.70(-4.46%)
At close: 12:30 AM EST
TWD 15TWD 17.5TWD 20Aug 10Aug 24Sep 7Sep 21Oct 5Oct 19Nov 2
Day’s Range
TWD 14.35 - TWD 15.20
52-Week Range
TWD 14.35 - TWD 23.90
Previous Close
TWD 15.70
Volume
N/A
Average Volume (3M)
250.30K
Market Cap
TWD 870.86M
Enterprise Value
TWD 790.40M
Total Cash (Recent Filing)
TWD 395.82M
Total Debt (Recent Filing)
TWD 220.26M
Price to Earnings (P/E)
―
Beta
0.70
Next Earnings
N/A
EPS Estimate
N/A
Last Dividend Ex-Date
Jul 28, 2023
Dividend Yield
N/A

4171 FAQ

What was GeneReach Biotechnology Corp.’s price range in the past 12 months?
GeneReach Biotechnology Corp. lowest stock price was TWD 14.35 and its highest was TWD 23.90 in the past 12 months.
What is GeneReach Biotechnology Corp.’s market cap?
GeneReach Biotechnology Corp.’s market cap is TWD 870.86M.
When is GeneReach Biotechnology Corp.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were GeneReach Biotechnology Corp.’s earnings last quarter?
GeneReach Biotechnology Corp. released its earnings results on Nov 12, 2026. The company reported -TWD 0.276 earnings per share for the quarter.
Is GeneReach Biotechnology Corp. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does GeneReach Biotechnology Corp. pay dividends?
GeneReach Biotechnology Corp. pays a ― dividend of TWD 1.5 which represents an annual dividend yield of ―. See more information on GeneReach Biotechnology Corp. dividends here
What is GeneReach Biotechnology Corp.’s EPS estimate?
GeneReach Biotechnology Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does GeneReach Biotechnology Corp. have?
GeneReach Biotechnology Corp. has 58,057,470 shares outstanding.
What happened to GeneReach Biotechnology Corp.’s price movement after its last earnings report?
GeneReach Biotechnology Corp. reported an EPS of -TWD 0.276 in its last earnings report. Following the earnings report the stock price went down -0.29%.
Which hedge fund is a major shareholder of GeneReach Biotechnology Corp.?
Currently, no hedge funds are holding shares in TW:4171
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology